922 results on '"Chitty, Lyn S."'
Search Results
202. Emerging Considerations for Noninvasive Prenatal Testing
203. Development and evaluation of training resources to prepare health professionals for counselling pregnant women about non-invasive prenatal testing for Down syndrome: a mixed methods study
204. Clinical, social and ethical issues associated with non-invasive prenatal testing for aneuploidy
205. Evaluation of Array Comparative genomic Hybridisation in prenatal diagnosis of fetal anomalies: a multicentre cohort study with cost analysis and assessment of patient, health professional and commissioner preferences for array comparative genomic hybridisation
206. The 100 000 Genomes Project: What it means for paediatrics
207. Uptake, Outcomes, and Costs of Implementing Non-invasive Prenatal Testing for Down Syndrome Into NHS Maternity Care: Prospective Cohort Study in Eight Diverse Maternity Units
208. Prenatally diagnosed congenital cystic adenomatoid malformation (CCAM) and pulmonary sequestration (PS): Long-term follow-up of 119 cases
209. A qualitative study looking at informed choice in the context of non‐invasive prenatal testing for aneuploidy
210. Mutations in Citron Kinase Cause Recessive Microlissencephaly with Multinucleated Neurons
211. Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down’s syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units
212. The 2015 Malcolm Ferguson-Smith Young Investigator Award
213. Non‐invasive prenatal diagnosis (NIPD) for single gene disorders: cost analysis of NIPD and invasive testing pathways
214. Women’s Experiences and Preferences for Service Delivery of Non-Invasive Prenatal Testing for Aneuploidy in a Public Health Setting: A Mixed Methods Study
215. Limited Clinical Utility of Non-invasive Prenatal Testing for Subchromosomal Abnormalities
216. Inositol for prevention of neural tube defects: a pilot randomised controlled trial – CORRIGENDUM
217. Inositol for the prevention of neural tube defects: a pilot randomised controlled trial
218. Noninvasive Prenatal Diagnosis for Cystic Fibrosis
219. Limited Clinical Utility of Non-invasive Prenatal Testing for Subchromosomal Abnormalities
220. Non-invasive prenatal testing for aneuploidy and beyond : challenges of responsible innovation in prenatal screening
221. Non-invasive prenatal testing for aneuploidy and beyond:challenges of responsible innovation in prenatal screening
222. Non-invasive prenatal testing for aneuploidy and beyond:challenges of responsible innovation in prenatal screening. Summary and recommendations
223. Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening. Summary and recommendations.
224. Current controversies in prenatal diagnosis 2: should a fetal exome be used in the assessment of a dysmorphic or malformed fetus?
225. Preferences for prenatal tests for Down syndrome: an international comparison of the views of pregnant women and health professionals
226. Variability of ffDNA in maternal plasma does not prevent correct classification of trisomy 21 using MeDIP‐qPCR methodology
227. Clinical, social and ethical issues associated with non-invasive prenatal testing for aneuploidy.
228. Stakeholder views and attitudes towards prenatal and postnatal transplantation of fetal mesenchymal stem cells to treat Osteogenesis Imperfecta
229. 21 - Congenital Lung Disease
230. Fetal forearm anomalies: prenatal diagnosis, associations and management strategy
231. Development and validation of a measure of informed choice for women undergoing non-invasive prenatal testing for aneuploidy
232. Next generation sequencing and the next generation: how genomics is revolutionizing reproduction
233. Non‐invasive prenatal testing for aneuploidy: a systematic review of Internet advertising to potential users by commercial companies and private health providers
234. Noninvasive Prenatal Screening for Genetic Diseases Using Massively Parallel Sequencing of Maternal Plasma DNA
235. The 2014 Malcolm Ferguson-Smith Young Investigator Award
236. Non‐invasive prenatal diagnosis of achondroplasia and thanatophoric dysplasia: next‐generation sequencing allows for a safer, more accurate, and comprehensive approach
237. Spina bifida
238. Use of Cell-free DNA to Screen for Down's Syndrome
239. Non‐invasive prenatal diagnosis for cystic fibrosis: detection of paternal mutations, exploration of patient preferences and cost analysis
240. Diagnostic accuracy of post mortem MRI for abdominal abnormalities in foetuses and children
241. Diagnostic Accuracy of Routine Antenatal Determination of Fetal RHD Status Across Gestation
242. In case you missed it: thePrenatal Diagnosiseditors bring you the most significant advances of 2014
243. The Role of Sonographic Phenotyping in Delivering an Efficient Noninvasive Prenatal Diagnosis Service for FGFR3-Related Skeletal Dysplasias
244. Lung aeration on post-mortem magnetic resonance imaging is a useful marker of live birth versus stillbirth
245. An easy test but a hard decision: ethical issues concerning non-invasive prenatal testing for autosomal recessive disorders
246. RECENT DEVELOPMENTS IN NON-INVASIVE PRENATAL DIAGNOSIS AND TESTING
247. Implementing Non-Invasive Prenatal Diagnosis (NIPD) in a National Health Service Laboratory; From Dominant to Recessive Disorders.
248. Abnormal fetal head shape: aetiology and management
249. The natural history of prenatally diagnosed congenital cystic lung lesions: long-term follow-up of 119 cases.
250. Evaluation of preferences of women and healthcare professionals in Singapore for implementation of noninvasive prenatal testing for Down syndrome.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.